06:57 AM EDT, 08/07/2025 (MT Newswires) -- Elanco Animal Health ( ELAN ) reported Q2 non-GAAP earnings Thursday of $0.26 per diluted share, down from $0.30 a year earlier.

Analysts surveyed by FactSet expected $0.20.

Revenue for the quarter ended June 30 was $1.24 billion, up from $1.18 billion a year earlier.

Analysts surveyed by FactSet expected $1.19 billion.

Elanco said it expects Q3 adjusted EPS of $0.12 to $0.16 on revenue of $1.08 billion to $1.11 billion. Analysts are looking for $0.13 and $1.09 billion, respectively.

The company now expects 2025 adjusted EPS of $0.85 to $0.91 on revenue of $4.57 billion to $4.62 billion. It previously projected adjusted EPS at $0.80 to $0.86 on revenue of $4.51 billion to $4.58 billion.

Analysts are looking for $0.84 and $4.55 billion, respectively.

Elanco shares were up 9.3% in recent premarket activity.